SI1631313T1 - Kombinirana terapija za B-celične motnje - Google Patents
Kombinirana terapija za B-celične motnjeInfo
- Publication number
- SI1631313T1 SI1631313T1 SI200432241T SI200432241T SI1631313T1 SI 1631313 T1 SI1631313 T1 SI 1631313T1 SI 200432241 T SI200432241 T SI 200432241T SI 200432241 T SI200432241 T SI 200432241T SI 1631313 T1 SI1631313 T1 SI 1631313T1
- Authority
- SI
- Slovenia
- Prior art keywords
- combination therapy
- cell disorders
- disorders
- cell
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47648103P | 2003-06-05 | 2003-06-05 | |
US47641403P | 2003-06-05 | 2003-06-05 | |
US47653103P | 2003-06-06 | 2003-06-06 | |
PCT/US2004/017693 WO2005000351A2 (en) | 2003-06-05 | 2004-06-04 | Combination therapy for b cell disorders |
EP04754321.0A EP1631313B1 (en) | 2003-06-05 | 2004-06-04 | Combination therapy for b cell disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1631313T1 true SI1631313T1 (sl) | 2015-06-30 |
Family
ID=37003283
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200432245T SI2272868T1 (sl) | 2003-06-05 | 2004-06-04 | Kombinirana terapija za B-celične motnje |
SI200432241T SI1631313T1 (sl) | 2003-06-05 | 2004-06-04 | Kombinirana terapija za B-celične motnje |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200432245T SI2272868T1 (sl) | 2003-06-05 | 2004-06-04 | Kombinirana terapija za B-celične motnje |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1835972A (sl) |
DK (1) | DK2272868T3 (sl) |
SI (2) | SI2272868T1 (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101851278B (zh) * | 2010-05-26 | 2013-03-13 | 石药集团中奇制药技术(石家庄)有限公司 | B细胞激活因子拮抗剂及其制备方法与用途 |
JP6271254B2 (ja) * | 2011-02-28 | 2018-01-31 | ジェネンテック, インコーポレイテッド | B細胞アンタゴニストに対する生物学的マーカー及び応答を予測するための方法 |
MX2013011385A (es) * | 2011-04-01 | 2014-03-13 | Immunogen Inc | Moleculas de union a cd37 y sus inmunoconjugados. |
CN103936833B (zh) * | 2014-04-18 | 2016-02-10 | 天津大学 | BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白 |
CN113136365A (zh) * | 2021-04-29 | 2021-07-20 | 中山大学附属口腔医院 | 基于组蛋白去乙酰化酶抑制活性诱导调节性b细胞高效扩增的试剂及其应用 |
-
2004
- 2004-06-04 SI SI200432245T patent/SI2272868T1/sl unknown
- 2004-06-04 SI SI200432241T patent/SI1631313T1/sl unknown
- 2004-06-04 DK DK10009416.8T patent/DK2272868T3/en active
- 2004-06-04 CN CNA2004800222478A patent/CN1835972A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1835972A (zh) | 2006-09-20 |
SI2272868T1 (sl) | 2015-07-31 |
DK2272868T3 (en) | 2015-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1631313T3 (pl) | Terapia skojarzona zaburzeń z komórek B | |
AU2003259152A8 (en) | Cell therapy for regeneration | |
AU2003282679A8 (en) | Hydroxypyrazoles for use against metabolic-related disorders | |
GB0307918D0 (en) | Therapeutic use | |
IL177155A0 (en) | Therapeutic combinations | |
GB0218526D0 (en) | Combination therapy | |
GB0417481D0 (en) | Combination therapy | |
GB0428180D0 (en) | Combination therapy | |
GB0300586D0 (en) | Therapeutic microfoam | |
GB0323258D0 (en) | Therapeutic compounds | |
GB0424339D0 (en) | Combination therapy | |
GB0328588D0 (en) | Collimator | |
SI1631313T1 (sl) | Kombinirana terapija za B-celične motnje | |
GB0417558D0 (en) | Novel combination therapy | |
GB0303289D0 (en) | Combination therapy | |
AU2003231937A8 (en) | Therapeutic methods | |
GB0325021D0 (en) | Therapeutic combinations | |
GB0421438D0 (en) | Combination therapy | |
GB0421436D0 (en) | Combination therapy | |
GB0213383D0 (en) | Therapeutic conditions | |
GB0316176D0 (en) | Combination therapy | |
GB0329512D0 (en) | Combination therapy | |
GB0307560D0 (en) | Combination therapy | |
GB0316181D0 (en) | Combination therapy | |
GB0318311D0 (en) | Combination therapy |